Summary. The interference of adrenal hormones with the oestradiol-induced modifications of endocrine pancreatic function remains controversial. For this reason, we compared sham-operated, ovariectomized and adrenalectomized-ovariectomized female rats. In each group, control and 17-fl-oestradiol-treated rats (0.1 mg/day for 14 days) were studied, the latter group being compared with similar rats treated with corticosterone (0.4mg/day). Oestradiol treatment induced hypoglycaemia and hyperinsulinism in basal and glucose-stimulated states, and hypoglucagonaemia. The presence of adrenal glands was necessary for the full expression of oestradiol effects on pancreatic islet B cells: in adrenalectomized-ovariectomized rats, oestradiol treatment induced an unexpected decrease in insulin response to intravenous glucose, and in pancreatic insulin content. Corticosterone treatment partly restored the oestradiol-induced rise of plasma insulin, and restored the B cell response to intravenous glucose. A permissive action of glucocorticoids may be a prerequisite for the effect of oestrogens on B cells. Since oestrogens by themselves augment the plasma corticosterone level, the insulinotropic effect of oestrogens may be partly mediated by the increase in endogenous corticosteroids. In contrast, oestradiol seems to suppress islet A cell function.
in water was substituted for water after adrenalectomy. Body weight and food ingestion were monitored throughout the study. The animals were divided into four groups: (1) sham-operated, (2) ovariectomized, (3) adrenalectomized-ovariectomized and (4) adrenalectomized-ovariectomized-corticosterone-treated. After a 8-day post-operative recovery period, the rats received SC injections of 17-/3-oestradiol twice daily for 14 days (Sigma Chemicals, St. Louis, USA). This hormone was dissolved in ethanol and olive oil (2.5/97.5, v/v) to a final concentration of 0.05 mg in 0A ml, supplemented or not with corticosterone (Fluka, Buchs, Switzerland). The dosage of corticosterone was 0.2 mg twice daily; control animals received vehicle alone. The last injection was given 20h before each study to avoid oil interference with fasting.
Experimental Procedures
Intravenous glucose tolerance tests were performed under pentobarbital anaesthesia (5 mg/100g body weight, IP) on animals fasted for 20 h. A polyethylene catheter was inserted into the jugular vein and kept patent with use of heparin (Choay, Paris, 50 U/kg body weight). Twenty minutes later blood samples (300 ~1) were collected in 1-U dried heparinized microtubes at zero time and 2, 10, 20 and 40min after an IV injection of glucose (300mg/ml; 0.1ml/t00g body weight). All the solutions used were at 37 ~ and the animals were maintained euthermic.
Blood samples from fed rats were collected after decapitation between 09.00 and 10.00h into dried heparinized tubes (t U). For glucagon assays, 500 U iniprol (Choay, Paris) had been added to heparin. Results presented are those before operation, 8 days later after a recovery period but before treatment, and on day 14 of oil or oestradiol (E2) treatment in sham-operated, ovariectomized and adrenalectomized-ovariectomized rats supplemented or not with corticosterone. Results expressed as mean + SEM; ap < 0.01 versus sham oil-treated control rats; bp < 0.001 versus sham-operated oil-treated control rats; ~ < 0.001 versus ovariectomized-oil-treated control rats; dp < 0.01 versus Ertreated sham group; ep < 0.001 versus Ee-treated sham group; fp < 0.05; gp < 0.01 ; hp < 0.00l versus respective oil-treated control groups; iwater was replaced by NaC1 0.9% solution in water.
After centrifugation at 4 ~ C, plasma samples were frozen at -20 ~ until assay. Pancreatic insulin was extracted by acidified ethanol (HC1 1tool/l; ethanol, 1:5, v/v), 20ml/g wet pancreas; 0.5 ml of this extract was precipitated by 2 ml ether-ethanol (2:1, v/v, pH 8.5), then redissolved in 1 ml acetic acid (1 mol/1) and diluted ( x 500) before insulin assay. Results were corrected by a 73% extraction yield, assessed from ten 125I-iodinated insulin samples run in parallel.
Analytical Methods
Glucose was measured by a glucose oxidase method [19] and insulin by radioimmunoassay [20] using rat insulin as a standard (Novo, Copenhagen, Denmark). Sensitivity of the insulin assay was 3 mU/1 for values lower than 25 mU/1, with a coefficient of variation of 21%; and 13 mU/l with coefficient of variation of 7% for values lower than 125 mU/1. Glucagon was determinated by a radioimmunoassay technique [21] using 30 K anti-serum (from Dr. R. Unger, Dallas, Texas) with a sensitivity of 21 pg/ml and a whole plasma coefficient of variation < 15%. Progesterone and oestradiol were assayed by radioimmunoassay methods [22, 23] with sensitivities of 20 pg/ml and 0.1 ng/ml respectively, interassay coefficients of variation being < 15%. In control rats, samples for these measurements were collected at time of oestrus. Corticosterone was measured by a competitive-protein binding assay [24] using 5% dog plasma, after dichloromethane extraction and paper chromatography with solvent system Bush B5. Sensitivity was 0.14 ng/ml, coefficient of variation 7%, and extraction coefficient 58%. Interference with the oestradiol assay was < 0.003% for corticosterone and progesterone, and < 1% for oestrone and oestriol. Interference with the progesterone assay was < 7% for desoxycorticosterone, < 3% for dihydro-and hydroxyprogesterone, and < 0.001% for oestradiol or cortisol. Percentage of bound corticosterone or progesterone was determined by an equilibrium dialysis technique [25] adapted to small plasma volumes [26] . Plasma volume was measured in five control and five E2-treated animals by the Evans blue plasma diffusion technique (after IV injection of 0.2 ml of 0.25% Evans blue solution in 0.9% NaC1).
Calculations
Results are expressed as mean _+ SEM. Statistical significance of differences was established using the Student's t-test for unpaired samples. Glucose disappearance coefficient (I~) was calculated from logeC -loge 2 time 2 to 40rain from formula: K~ = 0"693where t is t t the time (min) necessary for glucose rate to fall from concentration c to _c (g/l). Insulin response curve areas were evaluated by trapezoid-2 al integration from time 0 to 40 rain (mU/l • 40 min).
Results

Body Weight, Food and Fluid Intake (Table 1)
There was no difference between the various groups in body weight before treatment, i. e. after a 8-day post-operative recovery period. On day 14 of treatment, weight gain was significant in the oil-treated ovariectomized rats (Table 1) . Food intake decreased transiently during the 2 days following surgery in all groups. No further variation occurred in oil-treated rats. All E2-treated rats displayed a decrease in food intake for the first 6 days of E2 treatment. A subsequent increase towards control levels occurred later in sham-operated-E2-treated rats; slight but significant differences persisted in other Eztreated groups (Table 1) .
Fluid intake was not significantly affected by surgery itself. It increased after a few days in adrenalectomized-ovariectomized animals. The E~ treatment in- Results presented are those of oil or oestradiol (E2) treated rats after 14 days. Results expressed as mean + SEM (number of determinations in parentheses); ap < 0.001 ; bp < 0.01; Cp < 0.05 versus sham-operated control rats; dp < 0.05 versus ovariectomized control rats Results expressed as mean + SEM. For details of procedure see text: "p < 0.05; bp < 0.01 ; ~ < 0.001 versus sham control rats; dp < 0.05; ep < 0.01 ; fp < 0.001 versus ovariectomized control rats; gp < 0.001 versus ovariectomized-adrenalectomized control group; hp < 0.05 ; ip < 0.001 versus sham and ovariectomized Ez-treated rats;Jp < 0.01 versus Ez-treated adrenalectomized-ovariectomized rats and p < 0.001 versus Ez-treated sham or ovariectomized rats; kp < 0.001 versus E2-treated adrenalectomized-ovariectomized rats; lp < 0.05 ;mp < 0.01 ; "p < 0.001 versus respective oil control groups creased fluid intake in the ovariectomized rats and even more in the adrenalectomized-ovariectomized group (Table 1) .
Plasma Volume and Steroid Concentrations
Rat plasma volume was not modified by the various treatments (Table 2) .
Plasma oestradiol concentration was, for the control group, in the normal range for the time of oestrus. In ovariectomized rats, plasma oestradiol did not decrease significantly. In contrast, it became unmeasurable in adrenalectomized-ovariectomized rats. In Ez-treated groups, plasma oestradiol levels were higher than normal values for non-pregnant rats, in the range of late gestational values (683 _ 60 pg/ml; n = 6 on day 20 of gestation).
Plasma progesterone in control rats was 11.5 • 2.2 ng/ml, a value consistent with early oestrus. It was very low after ovafiectomy and even lower after adrenalectomy in oil and E2-treated groups. It was threefold higher than the control value in sham-operated E2-treated rats. The percentage of bound progesterone was not modified by E2 treatment (89.7 + 0.5 versus 88.8 + 0.4%; n = 4 in each group).
Plasma corticosterone was in the normal range for the control and ovariectomized rats, but it declined dramatically in all adrenalectomized rats but remained detectable. In non-adrenalectomized rats, E2 treatment induced a fourfold increase in plasma corticosterone level. The proportion of bound hormone was not modified by this treatment: 91.3 + 0.6% in untreated versus 90.1 + 0.5% in E2-treated sham-operated rats, and 90.0 + 0.8% versus 86.9 + 0.5% for the corresponding cas- 
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~ , Values are mean + SEM; number of results indicated under panels. *p < 0.05; **p < 0.01; ***p < 0.001 versus respective oil-treated controls; ap < 0.001 versus all oil-treated groups; bp < 0.01 versus sham and ovariectomized controls; ~ < 0.001 versus oil or E2-treated sham and ovariectomized rats; dp < 0.01 versus sham controls; ep < 0.05 versus E2-treated adrenalectomized-ovariectomized without corticosterone treatment but p < 0.001 versus other E2-treated non adrenalectomized rats; fp < 0.01 versus sham controls; gp < 0.001 versus sham controls and p < 0.01 versus other controls; hp < 0.001 versus sham controls and p < 0.05 versus other controls; ip < 0.05 versus sham controls; Jp < 0.001 versus sham controls trated rats (n = 4 in each group). When rats were supplemented with corticosterone (0.4mg/day), plasma corticosterone was higher than in sham controls, but still lower than in E2-treated sham animals. In adrenalectomized-ovariectomized rats treated with a high dose of corticosterone (1 mg/day), plasma corticosterone levels were 226.9 + 39.2 ng/ml in oiltreated rats (n = 6, p < 0.001) and 294.5 _+ 33.9 ng/ml in E2-treated rats (n = 6, p < 0.001), well above physiological values. (Table 3 , Fig. l) Fasting plasma glucose was significantly lowered by adrenalectomy and augmented by corticosterone treatment. This pattern was accentuated by E2 treatment.
Basal Plasma Glucose, Insulin and Glucagon
Fasting plasma insulin was lowered by adrenalectomy; this was corrected by corticosterone treatment. Oestradiol treatment significantly increased plasma insulin levels in fasted sham-operated and ovariectomized rats but had no effect in adrenalectomized rats, including the corticosterone-supplemented group. In fed rats, the glucose-lowering influence of adrenalectomy was no longer apparent but that of E2 treatment persisted (Fig. 1, upper panel) . By contrast, the influence of adrenalectomy on plasma insulin levels persisted. It was still lower than plasma insulin concentration in sham controls and in ovariectomized rats. Furthermore, corticosterone treatment restored basal insulin to normal values. A major observation was that oestradiol treatment significantly increased insulin concentration only when the adrenal glands were intact (sham-operated and ovariectomized groups). This was not the case in adrenalectomized-ovariectomized rats. In these rats oestradiol treatment constrastingly induced a significant decrease in plasma insulin (Fig. 1, central panel) . But when these adrenalectomized-ovariectomized rats were supplemented with corticosterone, the insulin-enhancing effect of oestradiol was partially restored: 44 + 6mU/1 (n = 13) versus 29 + 3mU/1 (n = 12; p < 0.05). However, this value of 44 + 6 mU/1 remained much lower than that measured in E2-treated (nonadrenalectomized) rats (101 + 10mU/1, n = 19; p < 0.001).
Plasma glucagon (Fig. 1, lower panel) concentration was increased by ovariectomy and even more so by adrenalectomy. Corticosterone supplementation induced a slight decrease in plasma glucagon though values remained higher than in other controls. Oestradiol treatment had no effect in sham group but reversed the glucagon rise induced by ovariectomy and reduced the glucagon rise induced by adrenalectomy (Fig. 1, lower  panel) .
Intravenous Glucose Load (Table 3)
The pattern of B cell responses to acute IV glucose loading was very similar to that obtained from basal insulin measurements. The areas of the insulin response curve to glucose were significantly higher in E2-treated rats (ovariectomized or not) than in the control group, when adrenal glands were maintained. In adrenalectomizedovariectomized rats, the B cell response was lower than in the sham-operated or ovariectomized groups, and E2 treatment lowered it even more: this latter effect contrasted markedly with the effect of E2 in other groups. Corticosterone treatment reversed this inhibitory effect of E2 in adrenalectomized animals. The reduction in B cell response from the E2-treated adrenalectomized rats, reversed by corticosterone, was particularly apparent for the earlier sampling times following a glucose load (peak value at 2 min was 93 _+ 13 mU/1 in adrenalectomized-ovariectomized rats versus 34 _+ 9 mU/1 in Eztreated-adrenalectomized-ovariectomized rats; p < 0.001 and 77 _+ 12 mU/1 with corticosterone supplementation, p < 0.02 versus 34 mU/1 and NS versus 93 mU/1).
The glucose disappearance coefficient in the control group was not significantly different from that obtained in E2-treated intact rats, ovariectomized rats and the ovariectomized-E2-treated group. It was significantly lower than the control value in adrenalectomized-Eztreated rats. These differences in slope of glucose disappearence occurred in spite of the fact that plasma glucose peaks were identical in all groups. Corticosterone treatment reversed the effect of adrenalectomy in oiltreated group but delayed glucose disappearance in Eztreated group.
Insulin Content of Pancreas
Pancreatic weight was not significantly different between groups and ranged from 778 _+ 41 mg in controls (n = 6) to 667 + 46 mg in adrenalectomized-ovariectomized-E2-treated rats (n = 6; NS). The insulin content of pancreas was not significantly affected in control groups (3.01 ___ 0.28, n = 6 for sham rats; 2.59 + 0.21, n = 11 for ovariectomized rats; and 2.73 _+ 0.36U/ pancreas, n = 12 for adrenalectomized-ovariectomized animals). It was significantly lower in the adrenalectomized-ovariectomized-Ez-treated rats (2.32 _+ 0.1 U/ pancreas, n = 6; p < 0.05) than in sham-operated control group or sham-operated E2-treated group (3.45 _+ 0.25, n = 7, p < 0.01) but not when compared with ovariectomized E2-treated rats (2.65 + 0.18, n = 10).
Discussion
Our results confirm that 14 days of treatment with the naturally occurring oestrogen 17-fl-oestradiol induce hypoglycaemia, hyperinsulinism and hypoglucagonaemia in the rat. Furthermore, the presence of adrenal glands was necessary for the full expression of these effects on B cells: in adrenalectomized-ovariectomized rats not treated by corticosterone, the oestradiol treatment induced an unexpected decrease in plasma insulin concentration and insulin content of the pancreas.
It is well known that oestradiol treatment can induce a rise in plasma insulin [27] [28] [29] and sometimes in pancreatic immunoreactive insulin concentrations [17, 27, 29] . It can also increase the B cell response to glucose in vivo [3, 30] and in vitro [3] [4] [5] 29] . The 'trophic effect' of oestrogens on islets has been likened to hyperinsulinism, islet hypertrophy and hyperplasia observed in late pregnancy [1, 31] . Discrepant influences of oestrogens on the tolerance to intravenous glucose have been documented [32] . These discrepancies can be due to a variety of experimental protocols and oestrogen preparations used, the results being obtained alternatively in intact or in castrated rats. Furthermore, interference of castration and/or oestrogen treatment with other endocrine glands and other target tissues was not always considered, particularly with regard to progesterone and adrenal steroids. Since endogenous progesterone was augmented by E2 treatment, progesterone could have interfered with oestrogen's direct influence on islets [3, 4, 33] . In the present work, specific analysis of the effects of E2 on castrated, progesterone-deprived rats tends to exclude progesterone as a mediator of E2 effects on the islet. The presence of adrenal glands appeared to be essential for the expression of E2 effects on glucoregulation and the B cell. Adrenalectomy not only suppressed the oestradiol-induced hyperinsulinism, but caused a decrease in plasma insulin and in pancreatic insulin content. Reduction in food intake and lower fasting plasma glucose values could account only partly for the negative influence of adrenalectomy and oestradiol on B cell function. Corticosteroid treatment by itself induces hyperinsulinism and islet hyperplasia [9] [10] [11] [12] 34] . High E2 levels in plasma are associated with high corticoid plasma concentrations in most physiological situations [13] . Glucocorticoids might therefore play a role in the Ez-induced insulin hypersecretion, and the changes in B cells induced by oestrogen treatanent might be due partly to the increased adrenocortical activity associated with 17-fl-oestradiol treatment.
In contrast with B ceils, oestrogens seemed to influence A cells directly. Ovariectomy induced a rise in plasma glucagon; this was corrected by oestradiol treatment, at least relatively, considering that plasma glucose was lower than normal at that time (Fig. 1) . Similarly, in adrenalectomized-ovariectomized rats whose plasma glucose levels were even lower than in other groups, plasma glucagon increased and this rise was reduced by oestrogen treatment. These results are compatible with a direct suppressive effect of oestradiol on A cells. Consistently, glucagon suppression by glucose is more pronounced in pregnant than non-pregnant women [6] , and the A cell response to alanine is reduced in oestrogen-treated rats [8] .
Further work is necessary to clarify the mechanism(s) of oestrogen/corticoid interference at the level of islet cells. A permissive action of glucocorticoids may be a prerequisite for the effect of oestradiol on B cells.
